Phase 4 N=90 Copper Intrauterine Device (IUD) Insertion at Cesarean Delivery
Intrauterine Device Expulsion
Primary: Number of Participants With Expulsion of IUD — 54; 0 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=7 Intrauterine Contraceptive Device (IUD) Placement at Time of C-Section
Contraception
Primary: Successful Retention of IUD — 7 participants
N/A N=123 Comparison of the Levonorgestrel IUD and the Copper IUD Placed in the Immediate Postplacental Period: A Prospective Cohort Study
Contraception
Primary: IUD Expulsion Rate — 20; 7 Participants
N/A N=57 Copper T380 IUD Versus Oral Levonorgestrel for Emergency Contraception vs. Plan B for Emergency Contraception
Pregnancy
Primary: Use of an Effective Method of Contraception at 6 Months After Requesting Emergency Contraception — 9; 13 participants
Phase 4 N=156 Immediate Versus Delayed Insertion of the Copper Intrauterine Device (IUD) After Medication Abortion
Contraception
Primary: Use of the IUD for Contraception at Six Months — 49; 51 participants — p=0.24
N/A N=51 A Pilot Study of Early Expulsion Rates of the IUB™ SCu380A
Contraception
Primary: Expulsion Rate — 9 participants
Phase 2 N=286 Evaluation of ContraMed VeraCept Intrauterine Copper Contraceptive for Long Acting Reversible Contraception
Contraception
Primary: The Primary Outcome Measure is Effectiveness as Calculated by the Pearl Index — 0.53; 1.41; 0.00 Pearl Index
N/A N=215 Immediate vs. Delayed Insertion of Copper T 380A IUD After Termination of Pregnancy Over 12-weeks Gestation
Contraception Behavior
Primary: Use of IUD — 58; 25 participants
Phase 4 N=28 Copper IUD Treatment Observation Study
Menorrhagia
Primary: Mean Days of Bleeding and Spotting, Spotting Only and Bleeding Only for the 84 Day Treatment Cycles and Last 28 Day Post-treatment Cycle — 29.2; 23.0; 9.3; 9.6 days…
N/A N=15 A Study to Evaluate the Safety and Initial Efficacy of a Novel Intrauterine Device
Contraception
Primary: Rates of Uterine Perforation — 0 Number of cases
Phase 4 N=23 Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial
Contraception
Primary: Retention Rate — 55; 75 percentage of randomized subjects — p=0.4003
N/A N=199 Comparison of Two Intrauterine Devices (IUDs) Among Cape Town HIV-positive Women
HIV
Primary: Participants With Detectable Genital Tract HIV Ribonucleic Acid (RNA) Viral Load (VL) — 18; 23; 10; 7 Participants — p=0.66
Phase 4 N=711 RAPID EC - Rct Assessing Pregnancy With Intrauterine Devices for EC
Contraception
Primary: Percentage of Participants Reporting a Pregnancy — 0; 0.3 % of participants reporting pregnancy
Phase 4 N=88 'Levonorgestrel IUD Insertion After D&E Procedure
Contraceptive Usage
Primary: The Primary Outcome is LNG-IUD Usage Six Months Following Enrollment. — 85.2; 62.9 percentage of participants — p=0.05
N/A N=40 Misoprostol With Intrauterine Device Insertion
Contraception
Primary: The Ease of IUD Insertion as Rated by the Provider Using a 100mm Visual Analog Scale (VAS). — 24; 29 mm
Phase 3 N=1,105 Compare Two Copper IUDs: Mona Lisa NT Cu380 Mini and ParaGard
Healthy Women · Female Contraception
Primary: Pregnancy Rate of Mona Lisa Copper IUD Over 3 Years — 1.86 Pearl Index = Num preg per 100 person yr
N/A N=79 Tracking IUD Bleeding Experiences: An Evaluation of Bleeding Profiles in New Intrauterine Device Users
Intrauterine Devices, Copper · Metrorrhagia · Menstruation
Primary: Evaluate Changes in Bleeding Duration Among Women Initiating the Copper T380 IUD During the 90 Days Prior to Initiation Compared to Two 90 Periods After IUD Insertion…
N/A N=112 Immediate Postplacental Insertion of IUDs at Time of Cesarean Delivery: A Randomized Clinical Trial
Intrauterine Devices · Cesarean Section
Primary: IUD Use — 32; 40 participants
N/A N=82 Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women
Pain
Primary: Patient Perceived Pain on a 100-point Visual Analogue Scale. — 0.5; 0.8; 5.8; 5.9 units on a scale
N/A N=120 Insertion of an Intrauterine Device (IUD) After Medical Abortion
Intrauterine Device Expulsion · Medical Abortion · Induced Abortion
Primary: Percentage of Women With Expulsion of an Intrauterine Device (IUD) Placed After Medical Abortion. — 4 percentage of participants
N/A N=67 Pain Control for Intrauterine Device Placement Using Paracervical Block
Pain Due to Intrauterine Contraceptive Device
Primary: Pain With Intrauterine Device (IUD) Placement — 54; 33 mm
N/A N=102 Postplacental or Delayed Insertion of the Levonorgestrel-releasing Intrauterine Device (IUD) After Vaginal Delivery
Contraception
Primary: IUD Usage Rate at 6 Months — 43; 39 participants
N/A N=108 Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women
Contraception
Primary: Provider Perceived Ease of Insertion on a 100-point Visual Analogue Scale (VAS) — 25.1; 27.4 units on a scale — p=0.64
Phase 4 N=29 A Pilot Study of Early Postpartum Intrauterine Contraception
Unplanned Pregnancy
Primary: IUD Expulsion — 11 Participants
N/A N=73 Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women
Contraception
Primary: Provider Perceived Ease of Insertion on a 100 Point Visual Analogue Scale — 21; 21 units on a scale
N/A N=7 Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Epithelial Ovarian Cancer
Primary: Cell Proliferation in the Fallopian Tube Fimbriae as Measured by Ki-67%+ — 8.3 percentage of positively stained cells
Phase 4 N=50 LNG-IUS at 2 Weeks Postpartum
Contraception · Malposition of Intrauterine Contraceptive Device
Primary: Number of Participants Who Would Recommend the LNG-IUS to a Friend at 6-months Postpartum. — 40 Participants
N/A N=150 Bleeding Patterns and Complications After Postpartum IUD Placement: a Pilot Study
Postpartum Period
Primary: Bleeding Patterns — 15; 18; 13; 7 days
Phase 3 N=2,885 Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study
Contraception
Primary: Pearl Index up to 3 Years — 0.33; 0.31 Pregnancies per 100 women years
N/A N=274 Levonorgestrel Intrauterine System For Emergency Contraception
Pregnancy, Unplanned · Pregnancy; Accident
Primary: Number of Participants With Pregnancy Following Emergency Contraception — 0; 0; 0; 6 Participants